Payment overview · 2025
General Payments
$753.25
5 reported records · 3 companies
Healthcare provider profile · identity verified
Rajesh Bhakta, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SUN CITY, AZ · NPI 1023077872
Verified facts
What the public records show
CMS Open Payments records show Rajesh Bhakta, M.D. received $753.25 in general payments during 2025 across 5 reported records.
Medtronic, Inc. accounted for 62.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$473.95 | 62.9% | 3 | 2025 |
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $144.15 | 19.1% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $135.15 | 17.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $753.25 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SYMPLICITY G3 Normalized: symplicity g3 |
Device | Medtronic, Inc. | $349.27 | 2 | 2025 |
Source payment records
|
|||||
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $144.15 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $135.15 | 1 | 2025 |
Source payment records
|
|||||
| PROTEGE RX Normalized: protege rx |
Device | Medtronic, Inc. | $124.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 897 | 247 |
| Atorvastatin Calcium | Atorvastatin Calcium | 681 | 220 |
| Losartan Potassium | Losartan Potassium | 560 | 174 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 533 | 183 |
| Gabapentin | Gabapentin | 413 | 143 |
| Amlodipine Besylate | Amlodipine Besylate | 386 | 127 |
| Montelukast Sodium | Montelukast Sodium | 353 | 119 |
| Omeprazole | Omeprazole | 326 | 107 |
| Lisinopril | Lisinopril | 323 | 107 |
| Metformin Hcl | Metformin Hcl | 318 | 104 |
| Pantoprazole Sodium | Pantoprazole Sodium | 301 | 100 |
| Pravastatin Sodium | Pravastatin Sodium | 285 | 88 |
| Tamsulosin Hcl | Tamsulosin Hcl | 266 | 90 |
| Tizanidine Hcl | Tizanidine Hcl | 214 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 188 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 175 | 62 |
| Trazodone Hcl | Trazodone Hcl | 175 | 63 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 162 | 67 |
| Potassium Chloride | Potassium Chloride | 158 | 56 |
| Carvedilol | Carvedilol | 153 | 47 |
| Buspirone Hcl | Buspirone Hcl | 152 | 39 |
| Metformin Hcl Er | Metformin Hcl | 141 | 48 |
| Furosemide | Furosemide | 140 | 53 |
| Famotidine | Famotidine | 139 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 137 | 47 |
| Ezetimibe | Ezetimibe | 120 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 119 | 39 |
| Eliquis | Apixaban | 116 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 36 |
| Azelastine Hcl | Azelastine Hcl | 110 | 63 |
| Atenolol | Atenolol | 109 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 105 | 41 |
| Simvastatin | Simvastatin | 100 | 34 |
| Memantine Hcl | Memantine Hcl | 95 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 94 | 36 |
| Glipizide | Glipizide | 93 | 34 |
| Ozempic | Semaglutide | 88 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 81 | 29 |
| Sertraline Hcl | Sertraline Hcl | 79 | 25 |
| Tramadol Hcl | Tramadol Hcl | 77 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 73 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 71 | 22 |
| Prednisone | Prednisone | 70 | 45 |
| Fenofibrate | Fenofibrate | 69 | 18 |
| Repaglinide | Repaglinide | 67 | 23 |
| Solifenacin Succinate | Solifenacin Succinate | 67 | 19 |
| Nifedipine Er | Nifedipine | 66 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 29 |
| Trulicity | Dulaglutide | 63 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 62 | 14 |
| Finasteride | Finasteride | 62 | 20 |
| Farxiga | Dapagliflozin Propanediol | 61 | 21 |
| Ibandronate Sodium | Ibandronate Sodium | 61 | 20 |
| Alendronate Sodium | Alendronate Sodium | 60 | 19 |
| Azithromycin | Azithromycin | 60 | 48 |
| Donepezil Hcl | Donepezil Hcl | 60 | 25 |
| Allopurinol | Allopurinol | 59 | 21 |
| Mounjaro | Tirzepatide | 58 | 14 |
| Jardiance | Empagliflozin | 57 | 19 |
| Methocarbamol | Methocarbamol | 57 | 22 |
| Methylprednisolone | Methylprednisolone | 57 | 49 |
| Dicyclomine Hcl | Dicyclomine Hcl | 55 | 20 |
| Januvia | Sitagliptin Phosphate | 54 | 14 |
| Pregabalin | Pregabalin | 53 | 14 |
| Spironolactone | Spironolactone | 53 | 15 |
| Mirtazapine | Mirtazapine | 52 | 15 |
| Alprazolam | Alprazolam | 51 | 15 |
| Ibuprofen | Ibuprofen | 50 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 13 |
| Folic Acid | Folic Acid | 49 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 48 | 16 |
| Glipizide Er | Glipizide | 47 | 22 |
| Clonidine Hcl | Clonidine Hcl | 46 | 15 |
| Estradiol | Estradiol | 46 | 19 |
| Propranolol Hcl | Propranolol Hcl | 44 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 21 |
| Repatha Sureclick | Evolocumab | 42 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 41 | 14 |
| Bupropion Xl | Bupropion Hcl | 40 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 40 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 23 |
| Glimepiride | Glimepiride | 38 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | 12 |
| Tradjenta | Linagliptin | 38 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | 15 |
| Lorazepam | Lorazepam | 37 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 34 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 34 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 24 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | 11 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Lovastatin | Lovastatin | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Prolia | Denosumab | 29 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | 14 |
| Levetiracetam | Levetiracetam | 27 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Lamotrigine | Lamotrigine | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | 12 |
| Cephalexin | Cephalexin | 25 | 24 |
| Irbesartan | Irbesartan | 25 | suppressed |
| Meloxicam | Meloxicam | 25 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 15 |
| Doxepin Hcl | Doxepin Hcl | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | 15 |
| Ketoconazole | Ketoconazole | 23 | 12 |
| Linzess | Linaclotide | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 22 | 18 |
| Latanoprost | Latanoprost | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 19 |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Ciclopirox | Ciclopirox | 20 | 13 |
| Dutasteride | Dutasteride | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 20 | suppressed |
| Naproxen | Naproxen | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 19 | suppressed |
| Pentoxifylline | Pentoxifylline | 19 | suppressed |
| Ssd | Silver Sulfadiazine | 19 | 16 |
| Telmisartan | Telmisartan | 19 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 13 |
| Lacosamide | Lacosamide | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 11 |
| Restasis | Cyclosporine | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 14 |
| Nystatin | Nystatin | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 12 |
| Estradiol (Once Weekly) | Estradiol | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Jublia | Efinaconazole | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $753.25 · 5 records | Medtronic, Inc. | PROTEGE RX, REZDIFFRA, SYMPLICITY G3, WATCHMAN FLX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error